Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy.

The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy. Cell. 2014 Jul 31; 158(3):564-78.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.